Most hemangiomas resolve on their own, but careful observation is suggested in all cases. One of the first signs of involution is a change in color, from a bright red color to a darker gray-red color. If hemangiomas persist and become symptomatic, further treatment might be required. More specifically, treatment should be considered if lesions cause life-threatening complications (e.g., hemangiomas in the airway, liver or GI tract); cause functional impairment (e.g., hemangiomas in the periorbital region that cause visual abnormalities); are very large (>5cm) and rapidly growing; or have the potential for permanent damage.
Treatment options include administering beta blockers, such as oral propranolol, or corticosteroids, such as oral prednisone. Both may cause side effects to the user (e.g., bradycardia, hypotension, bronchospasm, and hypoglycemia from beta blockers; and increased appetite, osteoporosis, acne, and lower resistance in infections from corticosteroids) and therefore treatment should be adjusted if side effects arise. Topical beta blockers (e.g., timolol) and topical corticosteroids (e.g., betamethasone) can be used for solitary, small, superficial lesions. Direct intralesional injection of steroids can also be considered.
Laser therapy is a treatment option typically used for persistent or remaining lesions. In such cases,
pulse dye laser treatment is commonly used. Surgical excision of hemangiomas is reserved for ulcerative, bleeding, and protruding hemangiomas. Additionally, hepatic hemangiomas may require surgical removal. Minimally invasive surgical techniques for hepatic hemangioma include arterial embolization, radiofrequency ablation, and hepatic radiation. A combination of more than one treatment option is often preferred in larger or resistant lesions.